Sign in

CIK 0001818794

  • Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364883909
Phone
+1 781-786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
Open-market buys, last 90 days
$40,000
in 1 filing
Open-market sales, last 90 days
$421,679
in 7 filings, $422K under 10b5-1 plans

Net −$381,679. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-13 Friedl-Naderer Johanna Chief Commercial Officer Sale 10b5-1 −231 $16.82 $4K 152,666
2026-11-13 Kerr Douglas Head of R&D and CMO Sale 10b5-1 −2,604 $16.82 $44K 167,960
2026-11-13 Lucera Erick Chief Financial Officer Sale 10b5-1 −1,991 $16.82 $33K 117,775
2026-11-13 Cox John CEO & President Sale 10b5-1 −5,513 $16.82 $93K 351,994
2026-10-20 Kerr Douglas Head of R&D and CMO Grant or award +8,000 170,564
2026-10-20 Kerr Douglas Head of R&D and CMO Grant or award · Stock option (right to buy) +12,000 12,000
2026-10-02 Posner Brian S Director Purchase +2,500 $16.00 $40K 27,000
2026-09-08 Friedl-Naderer Johanna Chief Commercial Officer Sale 10b5-1 −185 $18.88 $3K 152,897
2026-09-08 Kerr Douglas Chief Medical Officer Sale 10b5-1 −1,290 $18.88 $24K 162,564
2026-09-08 Cox John CEO & President Sale 10b5-1 −5,658 $18.88 $107K 357,507
2026-09-04 Friedl-Naderer Johanna Chief Commercial Officer Sale 10b5-1 −900 $24.35 $22K 153,082
2026-09-04 Kerr Douglas Chief Medical Officer Sale 10b5-1 −3,745 $24.35 $91K 163,854
2026-08-14 Rhodes Jason P Director Sale 10b5-1 −1,359,674 $25.00 $34.0M 2,441,454
2026-08-14 Rhodes Jason P Director Sale 10b5-1 −478,377 $25.00 $12.0M 567,358
2026-08-14 Rhodes Jason P Director Sale 10b5-1 −322,465 $25.00 $8.1M 428,946
2026-08-13 Friedl-Naderer Johanna Chief Commercial Officer Sale 10b5-1 −226 $26.28 $6K 153,982
2026-08-13 Kerr Douglas Chief Medical Officer Sale 10b5-1 −1,556 $26.28 $41K 167,599
2026-08-13 Lucera Erick Chief Financial Officer Sale 10b5-1 −1,797 $26.28 $47K 119,766
2026-08-13 Rhodes Jason P Director Sale 10b5-1 −268,354 $26.20 $7.0M 3,801,128
2026-08-13 Rhodes Jason P Director Sale 10b5-1 −94,415 $26.20 $2.5M 1,045,735

Page 1 of 41 · 818 trades